Dr. Plon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-822-4240
Summary
- Dr. Sharon Plon is a board-certified medical geneticist and a longstanding cancer genetics researcher identifying new cancer susceptibility genes and studying the implementation of genomic testing in medicine. Dr. Plon holds the Dan L Duncan Comprehensive Cancer Center Professorship at Baylor College of Medicine in the Departments of Pediatrics and Molecular and Human Genetics and a member of the Human Genome Sequencing Center. Dr. Plon also serves as Assistant Dean in the School of Medicine at Baylor College of Medicine. Dr. Plon serves as Principal Investigator with Donald (Will) Parsons and Amy McGuire on the NHGRI/NCI-U01 Texas KidsCanSeq multi-institutional trial that studies the incorporation of CLIA clinical genome-scale exome sequencing into the care of childhood cancer patients in the diverse patient populations in Texas. Since 2013, Dr. Plon has served as one of the Principal Investigators of the Clinical Genome (ClinGen) Resource and co-chairs the ClinGen Hereditary Cancer Clinical Domain. She also currently co-chairs the germline reporting effort of the national NCI/COG Pediatric MATCH Precision Oncology trial. Dr. Plon is a prior member of the American Society of Human Genetics Board of Directors and the NIH-National Advisory Council for Human Genome Research. She is a member of the 5th Edition Tumour Genetics Volume Editorial Board
Education & Training
- Harvard Medical SchoolClass of 1987
Certifications & Licensure
- TX State Medical License 1995 - 2026
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- Ten Years of Incidental, Secondary, and Actionable Findings.Sharon Plon, Gail Jarvik
The New England Journal of Medicine. 2023-11-09 - 1 citationsAssociations between birth defects and childhood and adolescent germ cell tumors according to sex, histologic subtype, and site.Jeremy M Schraw, Pagna Sok, Tania A Desrosiers, Amanda E Janitz, Peter H Langlois
Cancer. 2023-10-15 - 2 citationsCirculating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.Ross Mangum, Jacquelyn Reuther, Koel Sen Baksi, Ilavarasi Gandhi, Ryan C Zabriskie
Pediatric Hematology and Oncology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: